Urgotouch laser : laser scar removal

After a wound forms, a series of physiological mechanisms are triggered, leading to the gradual regeneration of injured tissues, known as healing. This process involves the renewal of collagen fiber cells, ultimately replacing damaged fibrous tissue.

Healing is a natural process that varies based on individuals and the affected injury areas. Factors influencing the duration and final scar appearance include:

• Patient’s age
• Skin type
• Tobacco use
• Cardiovascular health
• Genetic predisposition

Regardless, normal healing generally consists of three phases. The first phase begins immediately after the injury and lasts about two weeks, involving the body’s cleansing of the wound by removing damaged or necrotic tissue.

The second phase, lasting from 3 to 6 months, sees the wound turning red as collagen production and blood vessel renewal intensify.

The third and final phase typically spans 1 to 2 years. The skin gains elasticity, and the wound transitions into a whitish scar.

Developed by Urgo Medical, the UrgoTouch laser improves the appearance of scars by stimulating the healing process.

The laser emits specific thermal energy that penetrates deep into the skin tissues, stimulating collagen production, which enhances skin quality. The UrgoTouch device is equipped with a control system (the Scar Control System) that allows the practitioner to regulate the amount of emitted heat, ensuring safe and precise treatment.

Administered at the end of surgical interventions to minimize scarring, UrgoTouch laser treatment is performed in the operating room under anesthesia, causing no discomfort.

The UrgoTouch technology offers several advantages:

• It delivers excellent results regardless of skin type.
• A single laser application is sufficient.
• The treatment’s ability to reduce scar volume is clinically proven.
• Thousands of patients have already benefited from it, with documented success.

To assess the effectiveness of UrgoTouch laser, an independent clinical study was conducted on over 40 patients undergoing breast reduction. Scar quality was evaluated based on five specific parameters (pigmentation, vascularity, texture, thickness, and scar area). The study results showed an average improvement in scar volume of over 35% and more than 50% in some patients.

Dr. Benjamin Sarfati utilizes UrgoTouch technology and may recommend it at the conclusion of your surgical procedure if deemed appropriate during your initial consultation.